Inventor · disambiguated record
Taek Kwan Kwon
Also filed as: KWON TAEK · KWON TAEK KWAN
4 granted patents·12 pending applications·0 citations·filing 2012–2023
53Inventor score
Top patents by PatentIndex Score
16 records- 0160US2021154180A1Formulation having improved ph-dependent drug-release characteristics containing esomeprazole or pharmaceutically acceptable salt thereofHANMI PHARM IND CO LTD·Filed 2021·Application pending·0 cites
- 0259US2025268922A1Pharmaceutical composition comprising acetylsalicylic acid and proton pump inhibitorHANMI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0358US10946003B2Formulation having improved pH-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereofHANMI PHARM IND CO LTD·Filed 2017·Granted Mar 16, 2021·0 cites·6 claims
- 0458US2025032420A1Method for preparing oral composite tablet containing proton pump inhibitor and antacid and oral composite tablet prepared therebyHANMI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0552US2024325311A1Oral complex tablet comprising sitagliptin, dapagliflozin, and metforminHANMI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0651US9801876B2Complex granule formulation having improved stability comprising levocetirizine and montelukastHANMI PHARM IND CO LTD·Filed 2014·Granted Oct 31, 2017·0 cites·8 claims
- 0749US9486528B2Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereofHANMI PHARM IND CO LTD·Filed 2013·Granted Nov 8, 2016·0 cites·10 claims
- 0849US2022378790A1Pharmaceutical preparation comprising an amide derivative inhibiting the growth of cancer cell and a pharmaceutical product containing the sameHANMI PHARM IND CO LTD·Filed 2020·Application pending·0 cites
- 0946US2023149314A1Oral complex tablet comprising sitagliptin, dapagliflozin, and metforminHANMI PHARM IND CO LTD·Filed 2021·Application pending·0 cites
- 1043US2022202795A1Pharmaceutical composition comprising esomeprazole or pharmaceutically acceptable salt thereof and having double-release profileHANMI PHARM IND CO LTD·Filed 2020·Application pending·0 cites
- 1143US2014170213A1Capsule formulation comprising montelukast and levocetirizineKIM YONG II·Filed 2012·Application pending·0 cites
- 1242US2016089339A1Capsule formulation comprising montelukast and levocetirizineHANMI PHARM IND CO LTD·Filed 2015·Application pending·0 cites
- 1342US2017157108A1Liquid formulation comprising montelukast or pharmaceutically acceptable salt thereof and method for preparing sameHANMI PHARM IND CO LTD·Filed 2014·Application pending·0 cites
- 1442US2015098992A1Composite formulation comprising multi-unit spheroidal tablet (must) encapsulated in hard capsule and method for preparing sameHANMI PHARM IND CO LTD·Filed 2013·Application pending·0 cites
- 1540US11052048B2Esomeprazole-containing complex capsule and preparation method thereforHANMI PHARM IND CO LTD·Filed 2017·Granted Jul 6, 2021·0 cites·11 claims
- 1636US2017368049A1Composite capsules comprising raloxifene, and vitamin d or its derivativesHANMI PHARM IND CO LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Taek Kwan Kwon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →